Losses
The 2023 and 2024 financial years closed with a loss. 2024 was the heaviest.
The 2023 and 2024 financial years closed with a loss. 2024 was the heaviest.
Turnover rose in 2024 from €3.4m to €11.1m.
In 2024, 13 people joined and 10 left.
Antech Diagnostics Belgium pays its suppliers 185 days earlier than in 2023. Customers pay 104 days earlier.
Short-term debts fell from €46.1m to €1.9m.
2025 accounts not filed: deadline was 31-07-2026.
A confirmed filing finding caps the score at 59.
The dashed line is the sector median: 0.1% across 35 companies (NACE 75, small).
About 1 in 100 comparable companies go bankrupt within 12 months (an estimate).
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 75, small). It does better than 93% of them on solvency, 60% on liquidity, 23% on profitability and 99% on growth.
The bankruptcy probability was computed on 06-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
The probability rests on the annual accounts with balance sheet date 31-12-2024.
Of the companies with a bankruptcy probability in the low class on 30-06-2025, 0.8% went bankrupt within twelve months.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
In July 2024, 2,686 companies had the same profile as Antech Diagnostics Belgium has now. Each dot stands for 7 companies, two years later.
Another 0.3% stopped without a precise date, possibly only after those two years.
The bankruptcy probability of Antech Diagnostics Belgium itself is higher: 1.1% within 12 months. It rests on far more data about Antech Diagnostics Belgium than the profile alone.
The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,686 companies, not a prediction for Antech Diagnostics Belgium. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Liquidity is ample, with a current ratio of 2.15 (0.06 in 2023), above the usual 1.5. Short-term debt is 4.4% and cash 3.4% of total assets. 4.4% of the assets are financed with debt and provisions.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
The company filed its last 6 accounts on average 32 days after the deadline. In the sector (NACE 75), the median for financial year 2024 was 6 days before the deadline, and 36% of those companies filed late.
| Company | ||||
|---|---|---|---|---|
| Antech Diagnostics Belgium Namur | €11.1m | -28.0% | 95.6% | 33.5 |
| IDEXX LABORATORIES Brussels | €19.6m | 4.0% | 96.5% | 17.2 |
| UNIVET BELGIUM Enghien | €10.5m | -5.2% | -20.2% | 30.1 |
| NESTO Leuven | €2.6m | -4.1% | 30.1% | 12.4 |
| EQUITOM Lummen | €13.7m | -3.5% | 19.7% | 44.7 |
| ASSOCIATION REGIONALE DE SANTE ET D'IDENTIFICATION ANIMALES - REGIONALE VEREINGUNG DER TIERGESUNDHEIT UND - IDENTIFIZIERUNG Ciney | €11.0m | 7.3% | 77.8% | 136.9 |
| Natuurhulpcentrum Oudsbergen | - | - | 95.9% | 18.6 |
Grey: the largest companies of the sector (veterinary activities (NACE 75)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as Antech Diagnostics Belgium: veterinary services (NACE 75000). They are comparable in size and age: total assets between €8.5m and €51m, founded between 1981 and 2019.
Antech Diagnostics Belgium has existed since 2009. In 2023 turnover rose from €755,519 to €3.4m and staff from 1 to 6.5 full-time equivalents.
Solvency rose in 2024 from -0.1% to 95.6% because of lower debts.
Antech Diagnostics Inc. holds all the shares. In 2023, three directors stepped down. In December 2023, the Official Gazette published the appointment of David Garcia as managing director.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.